Cargando…

Twist contributes to hormone resistance in breast cancer by down-regulating estrogen receptor alpha

The role of estrogen receptor alpha (ER) in breast cancer development and as a primary clinical marker for breast cancer prognosis is well documented. In this study, we identified the oncogenic protein TWIST1 (Twist), which is over-expressed in high-grade breast cancers, as a potential negative regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vesuna, Farhad, Lisok, Ala, Kimble, Brian, Domek, John, Kato, Yoshinori, van der Groep, Petra, Artemov, Dmitri, Kowalski, Jeanne, Carraway, Hetty, van Diest, Paul, Raman, Venu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276743/ https://www.ncbi.nlm.nih.gov/pubmed/22056872 http://dx.doi.org/10.1038/onc.2011.483

Ejemplares similares

Genomic pathways modulated by Twist in breast cancer
por: Vesuna, Farhad, et al.
Publicado: (2017)

miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers
por: Vos, Shoko, et al.
Publicado: (2015)

Role of DDX3 in the pathogenesis of inflammatory bowel disease
por: Tantravedi, Saritha, et al.
Publicado: (2017)

Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity
por: Winnard, Paul T., et al.
Publicado: (2020)

Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation
por: Kerr, Candace L., et al.
Publicado: (2019)

Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
por: Tantravedi, Saritha, et al.
Publicado: (2018)

Expression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells
por: Botlagunta, Mahendran, et al.
Publicado: (2011)

Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach
por: Heerma van Voss, Marise R., et al.
Publicado: (2018)

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
por: Heerma van Voss, Marise R, et al.
Publicado: (2017)

NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3
por: Xie, Min, et al.
Publicado: (2015)

Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer
por: van Voss, Marise R. Heerma, et al.
Publicado: (2015)

Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related
por: Bos, Reinhard, et al.
Publicado: (2004)

Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer
por: Bol, Guus M., et al.
Publicado: (2013)

Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes
por: Winnard, Paul T., et al.
Publicado: (2017)

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast
por: Kuijper, Arno, et al.
Publicado: (2005)

Targeting DDX3 with a small molecule inhibitor for lung cancer therapy
por: Bol, Guus M, et al.
Publicado: (2015)

New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists
por: Carraway, Hetty, et al.
Publicado: (2004)

RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2
por: Vesuna, Farhad, et al.
Publicado: (2022)

Emerging therapies for acute myeloid leukemia
por: Saygin, Caner, et al.
Publicado: (2017)

Heterogeneity of Tumor Vasculature and Antiangiogenic Intervention: Insights from MR Angiography and DCE-MRI
por: Zhu, Wenlian, et al.
Publicado: (2014)

Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models
por: Hapuarachchige, Sudath, et al.
Publicado: (2016)

Expression Pattern of a Homeotic Gene, HOXA5, in Normal Breast and in Breast Tumors
por: Henderson, Gregory S., et al.
Publicado: (2006)

Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011)

Emerging treatment options for patients with high-risk myelodysplastic syndrome
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2020)

TWIST Represses Estrogen Receptor-alpha Expression by Recruiting the NuRD Protein Complex in Breast Cancer Cells
por: Fu, Junjiang, et al.
Publicado: (2012)

Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression
por: Hyseni, Agon, et al.
Publicado: (2011)

Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment
por: Heerma van Voss, Marise R., et al.
Publicado: (2017)

Efficient in vivo knock-down of estrogen receptor alpha: application of recombinant adenovirus vectors for delivery of short hairpin RNA
por: Krom, Yvonne D, et al.
Publicado: (2006)

Hemophagocytic Lymphohistiocytosis in a Patient With Hodgkin lymphoma and Concurrent EBV, CMV, and Candida Infections
por: Mustafa Ali, Moaath, et al.
Publicado: (2017)

Twist reverses muscle cell differentiation through transcriptional down-regulation of myogenin
por: Mastroyiannopoulos, Nikolaos P., et al.
Publicado: (2013)

Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer
por: Vermeulen, Jeroen F., et al.
Publicado: (2013)

Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
por: van Voss, Marise R Heerma, et al.
Publicado: (2010)

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011)

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
por: Hapuarachchige, Sudath, et al.
Publicado: (2020)

Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2007)

Superlattice structures in twisted bilayers of folded graphene
por: Schmidt, Hennrik, et al.
Publicado: (2014)

Estrogen Receptor α Mediates Proliferation of Osteoblastic Cells Stimulated by Estrogen and Mechanical Strain, but Their Acute Down-regulation of the Wnt Antagonist Sost Is Mediated by Estrogen Receptor β
por: Galea, Gabriel L., et al.
Publicado: (2013)

Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells
por: Hapuarachchige, Sudath, et al.
Publicado: (2016)

PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells
por: Al-Howail, Huda A., et al.
Publicado: (2016)

Twisted Radio Waves and Twisted Thermodynamics
por: Kish, Laszlo B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_trnr9crtn9feulsdku858g0l09